Umbilical cord blood stem cell transplantation for hematological and lymphoid malignancies in adults
Record ID 32014000375
Authors' recommendations: Umbilical cord blood transplantation (UCBT) is an alternative source of hematopoietic stem and progenitor cells for patients with hematological diseases that may be cured by allogeneic stem cell transplantation (SCT). While the largest successful experience with UCBT has been in the treatment of patients with hematological malignancies (e.g., leukemia, lymphoma, myelodysplastic syndromes), it has also been used to treat patients with some inherited and acquired conditions such as aplastic anemia, metabolic disorders, and autoimmune diseases. Other graft sources for SCT include bone marrow and peripheral blood.
Project Status: Completed
Year Published: 2013
URL for published report: The report may be purchased from: http://www.hayesinc.com/hayes/crd/?crd=16095
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
- Transplantation, Homologous
- Cord Blood Stem Cell Transplantation
- Lymph Nodes
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name: firstname.lastname@example.org
Contact Email: email@example.com
Copyright: 2013 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.